SCHEMBL4924540

SCHEMBL4924540

COc1ccc(Nc2cc(OC)ccc2N)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.67
RAB9A P51151 5/20 0.67
GAA P10253 4/20 0.67
ALDH1A1 P00352 4/20 0.67
TDP1 Q9NUW8 3/20 0.67
KDM4E B2RXH2 2/20 0.67
THRB P10828 2/20 0.67
RECQL P46063 2/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
HTT P42858 2/20 0.67
MMP14 P50281 1/20 0.67
NR4A1 P22736 1/20 0.58
MAPK1 P28482 3/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
NPC1 O15118 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
AKR1C3 P42330 7/20 0.57
AKR1C2 P52895 7/20 0.57
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19350739 0.93 NR4A1 (0.65) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL12069392 0.90 AKR1C3 (0.61) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL2817959 0.89 GAA (0.63) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL8885417 0.87 MAPT (0.56) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL24208167 0.87 MAPT (0.64) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL4933129 0.86 MAPT (0.59) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL14247862 0.86 MAPT (0.59) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL1624404 0.83 MAPT (0.49) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL14463426 0.82 MAPT (0.55) MAPTRAB9AGAAALDH1A1TDP1
SCHEMBL8938907 0.82 RAB9A (0.51) MAPTRAB9AGAAALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 MAPT 4574/4885RAB9A 3074/4885GAA 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.